We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Diagnostics

Image: Researchers identified blood-based genomic signatures characteristic of inflammatory breast cancer (photo courtesy of Shutterstock)

Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

An enhanced RNA-sequencing method identifies biomarkers that distinguish inflammatory breast cancer, enabling liquid biopsy. More...
08 May 2026
Image: The findings could enable noninvasive liquid biopsy profiling of the complex tumor microenvironment, helping guide precision oncology decisions across cancers and therapies (Photo credit: Shutterstock)

Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response

A first-of-its-kind blood test maps tumor ‘neighborhoods’ to improve prediction of immunotherapy benefit across cancers More...
08 May 2026
Image: The workflow seamlessly integrates the KingFisher Flex platform with the BioCode MDx-3000 system to expand panel utility and increase respiratory testing throughput (Photo courtesy of Thermo Fisher Scientific)

Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing

Applied BioCode’s BioCode Respiratory Pathogen Panel (RPP) has received FDA clearance for IVD use when paired with nucleic acid extraction on the Thermo Fisher Scientific's KingFisher Flex platform. More...
07 May 2026
Image: Overall workflow of the study. Targeted genes are ITGAM, PECAM1, CCL5, STAT1, STAT2, and CD44. (Dipanwita Nath et al, Cancer Medicine (2026). DOI: 10.1002/cam4.71775)

Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence

New data reveal shared inflammatory genes linking pancreatic cancer with obesity/diabetes, enabling better risk stratification. More...
07 May 2026
Image: Blood RNA markers  potential for detecting HIV and tuberculosis complications and tracking treatment response in inflammatory bowel disease (Photo courtesy of Shutterstock)

Whole-Blood RNA Test Predicts Disease Trajectory and Treatment Response

An AI approach to whole-blood RNA forecasts disease course and therapy response from one sample to aid triage. More...
07 May 2026
Image: The findings provide the first evidence that pre-treatment epigenetic signals in cfDNA can distinguish semaglutide responders from non-responders, with important implications for the future of precision medicine in GLP-1 therapy (Photo credit: Adobe Stock)

Blood-Based Epigenetic Test Predicts GLP-1 Response and Tracks Treatment Effects

A new blood-based cfDNA methylation test and AI platform predicts semaglutide responders pre-treatment. More...
07 May 2026
Image: The findings support tumor genomic testing in pituitary carcinomas and aggressive pituitary adenomas, to guide consideration of immunotherapy as a potential first-line option (photo courtesy of Adobe Stock)

Tumor Genomic Testing Guides Immunotherapy Selection in Pituitary Tumors

DNA testing for mismatch repair alterations guides immunotherapy, enabling complete responses in aggressive pituitary tumors. More...
05 May 2026
New
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
HPV Test
Allplex HPV28 Detection
New
Clinical Informatics Platform
CLARION™


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.